2022.Aug.08
The Company’s BOD resolved to forfeit the subscription of AP Biosciences’ cash capital increase and distribute the rights to its shareholders
1.Date of occurrence of the event:2022/08/08 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence: In accordance with related laws and regulations, to coordinate with AP Biosciences’ future plan of shareholding dispersal after IPO, to protect shareholders’ interests of the Company, and […]
This article is password protected.
To view the content, please enter your password in the field below